TEPLONEER Trademark

Trademark Overview

On Thursday, September 28, 2023, a trademark application was filed for TEPLONEER with the United States Patent and Trademark Office. The USPTO has given the TEPLONEER trademark a serial number of 98201839. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 27, 2024. This trademark is owned by Provention Bio, Inc.. The TEPLONEER trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of rheumatological diseases; pharmaceutical preparations for the prevention and treatment of Multiple Sclerosis; pharmaceutical preparations for use in organ and tissue transplantation; pharmaceutical preparations for the prevention and treatment of Graft versus Host Disease; pharmaceutical preparations for the prevention and treatment of Narcolepsy; pharmaceutical preparations for the prevention and treatment of Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED); pharmaceutical preparations for the prevention and treatment of Uveitis; pharmaceutical preparations for the prevention and treatment of Vitiligo; pharmaceutical preparations for the prevention and treatment of T cell Lymphoma and T cell Leukemia; pharmaceutical preparations for the ...
teploneer

General Information

Serial Number98201839
Word MarkTEPLONEER
Filing DateThursday, September 28, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, August 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements

Goods and Servicespharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of rheumatological diseases; pharmaceutical preparations for the prevention and treatment of Multiple Sclerosis; pharmaceutical preparations for use in organ and tissue transplantation; pharmaceutical preparations for the prevention and treatment of Graft versus Host Disease; pharmaceutical preparations for the prevention and treatment of Narcolepsy; pharmaceutical preparations for the prevention and treatment of Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED); pharmaceutical preparations for the prevention and treatment of Uveitis; pharmaceutical preparations for the prevention and treatment of Vitiligo; pharmaceutical preparations for the prevention and treatment of T cell Lymphoma and T cell Leukemia; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders and asthma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameProvention Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRed Bank, NJ 07701
Party NameProvention Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRed Bank, NJ 07701

Trademark Events

Event DateEvent Description
Wednesday, October 11, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 21, 2024ASSIGNED TO EXAMINER
Tuesday, May 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 2, 2023NEW APPLICATION ENTERED
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

teploneer preparations pharmaceutical treatment prevention cell diseases candidiasis ectodermal polyendocrinopathy autoimmune